These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 24484982

  • 1. Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects.
    Matsumoto RR, Nguyen L, Kaushal N, Robson MJ.
    Adv Pharmacol; 2014; 69():323-86. PubMed ID: 24484982
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Could sigma receptor ligands be a treatment for methamphetamine addiction?
    Rodvelt KR, Miller DK.
    Curr Drug Abuse Rev; 2010 Sep; 3(3):156-62. PubMed ID: 21054260
    [Abstract] [Full Text] [Related]

  • 4. Sigma-1 receptors: potential targets for the treatment of substance abuse.
    Robson MJ, Noorbakhsh B, Seminerio MJ, Matsumoto RR.
    Curr Pharm Des; 2012 Sep; 18(7):902-19. PubMed ID: 22288407
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Physiological functions of sigma-1 receptors and its relation to psychic dependence].
    Mori T, Yoshizawa K, Shibasaki M, Suzuki T.
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Dec; 47(6):279-86. PubMed ID: 23461216
    [Abstract] [Full Text] [Related]

  • 7. Sigma receptors: potential medications development target for anti-cocaine agents.
    Matsumoto RR, Liu Y, Lerner M, Howard EW, Brackett DJ.
    Eur J Pharmacol; 2003 May 23; 469(1-3):1-12. PubMed ID: 12782179
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sigma Receptors and Substance Use Disorders.
    Sabino V, Hicks C, Cottone P.
    Adv Exp Med Biol; 2017 May 23; 964():177-199. PubMed ID: 28315272
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL, Hiranita T, Hong WC, Job MO, McCurdy CR.
    Handb Exp Pharmacol; 2017 May 23; 244():177-218. PubMed ID: 28110353
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.
    Hayashi T, Su TP.
    CNS Drugs; 2004 May 23; 18(5):269-84. PubMed ID: 15089113
    [Abstract] [Full Text] [Related]

  • 14. Tic hydantoin sigma-1 agonist: pharmacological characterization on cocaine-induced stimulant and appetitive effects.
    Toussaint M, Delair B, Foulon C, Lempereur N, Vaccher C, Maurice T, Melnyk P.
    Eur Neuropsychopharmacol; 2009 Jul 23; 19(7):504-15. PubMed ID: 19249191
    [Abstract] [Full Text] [Related]

  • 15. [Effects of sigma receptor ligands on psychiatric disorders].
    Kamei H, Noda Y, Nabeshima T, Yamada K.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Oct 23; 23(5):187-96. PubMed ID: 14653224
    [Abstract] [Full Text] [Related]

  • 16. Sigma receptors as potential therapeutic targets for neuroprotection.
    Nguyen L, Kaushal N, Robson MJ, Matsumoto RR.
    Eur J Pharmacol; 2014 Nov 15; 743():42-7. PubMed ID: 25261035
    [Abstract] [Full Text] [Related]

  • 17. Clinical trials with sigma ligands.
    Volz HP, Stoll KD.
    Pharmacopsychiatry; 2004 Nov 15; 37 Suppl 3():S214-20. PubMed ID: 15547788
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals.
    Hashimoto K, Ishiwata K.
    Curr Pharm Des; 2006 Nov 15; 12(30):3857-76. PubMed ID: 17073684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.